Traws Pharma (TRAW) Tops Q1 EPS by 209c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q1 EPS of $2.09. Revenue for the quarter came in at $60 thousand.
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris Technologies (LHX) Tops Q3 EPS by 32c; offers guidance
- CRH plc (CRH) Tops Q3 EPS by 6c, cuts forecast
- MEDNAX (MD) Tops Q3 EPS by 7c, Beats on Revenue; Reaffirms EBITDA Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
